目的通过胶囊内镜所获取的图像在无创、生理条件下记录胃肠转运时间,并对其影响因素进行全面分析。方法对178例连续入选的患者行胶囊内镜检查,分析年龄、性别、体质量指数等各项临床参数对消化道转运时间的影响,同时分析胶囊未完成全小...目的通过胶囊内镜所获取的图像在无创、生理条件下记录胃肠转运时间,并对其影响因素进行全面分析。方法对178例连续入选的患者行胶囊内镜检查,分析年龄、性别、体质量指数等各项临床参数对消化道转运时间的影响,同时分析胶囊未完成全小肠检查的原因。结果124例患者完成全小肠检查,胶囊内镜检查中胃平均排空时间为44.5 m in,小肠平均通过时间为286 m in;年龄对小肠通过时间有影响(P<0.05),性别、体质量指数对消化道转运时间无影响(P>0.05)。年龄、小肠克罗恩病、小肠新生物为影响胶囊内镜未完成全小肠检查的因素。结论对年龄>60岁、有肠道克罗恩病史或疑诊肠道克罗恩病、怀疑小肠存在新生物的患者,行胶囊内镜检查前,应口服促肠道动力药以提高胶囊内镜检查效率。展开更多
Abstract Abstract Background: Video capsule endoscopy (VCE) will fail to reach the cecum in 20% of patients within the 8-hour battery life. The use of prokinetics to improve VCE completion rates to the cecum remains u...Abstract Abstract Background: Video capsule endoscopy (VCE) will fail to reach the cecum in 20% of patients within the 8-hour battery life. The use of prokinetics to improve VCE completion rates to the cecum remains unclear. The objective of this study was to determine whether erythromycin increases the completion rate of VCE to the cecum without adversely affecting image quality. Methods: This was a prospective, randomized, single-blinded control trial at St. Vincent’ s Hospital, Melbourne, Australia. A total of 86 consecutive patients referred for VCE were considered for entry; 45 patients met the entry criteria. These 45 patients were prospectively randomized to no erythromycin (controls, n = 23) or 250 mg erythromycin (n = 22). Two gastroenterologists, who were unaware of which group the patients were randomized into, reported all VCEs. The number of VCEs that reached the cecum within the 8-hour study period, gastric emptying time (GET), and small-bowel transit time (SBTT) were calculated for each group. Results: There was no significant difference in the number of VCEs that reached the cecum (32% failed to reach the cecum in the erythromycin group compared with 22% in the control group), GET, or SBTT between the two groups. Image quality was not adversely affected by the use of erythromycin. The dose and the preparation of erythromycin used in this study may have possibly had an effect on GET and SBTT. Conclusions: The use of erythromycin did not significantly increase the likelihood of the capsule reaching the cecum or affect the degree of visible peristalsis or the interpretation of capsule findings.展开更多
文摘目的通过胶囊内镜所获取的图像在无创、生理条件下记录胃肠转运时间,并对其影响因素进行全面分析。方法对178例连续入选的患者行胶囊内镜检查,分析年龄、性别、体质量指数等各项临床参数对消化道转运时间的影响,同时分析胶囊未完成全小肠检查的原因。结果124例患者完成全小肠检查,胶囊内镜检查中胃平均排空时间为44.5 m in,小肠平均通过时间为286 m in;年龄对小肠通过时间有影响(P<0.05),性别、体质量指数对消化道转运时间无影响(P>0.05)。年龄、小肠克罗恩病、小肠新生物为影响胶囊内镜未完成全小肠检查的因素。结论对年龄>60岁、有肠道克罗恩病史或疑诊肠道克罗恩病、怀疑小肠存在新生物的患者,行胶囊内镜检查前,应口服促肠道动力药以提高胶囊内镜检查效率。
文摘Abstract Abstract Background: Video capsule endoscopy (VCE) will fail to reach the cecum in 20% of patients within the 8-hour battery life. The use of prokinetics to improve VCE completion rates to the cecum remains unclear. The objective of this study was to determine whether erythromycin increases the completion rate of VCE to the cecum without adversely affecting image quality. Methods: This was a prospective, randomized, single-blinded control trial at St. Vincent’ s Hospital, Melbourne, Australia. A total of 86 consecutive patients referred for VCE were considered for entry; 45 patients met the entry criteria. These 45 patients were prospectively randomized to no erythromycin (controls, n = 23) or 250 mg erythromycin (n = 22). Two gastroenterologists, who were unaware of which group the patients were randomized into, reported all VCEs. The number of VCEs that reached the cecum within the 8-hour study period, gastric emptying time (GET), and small-bowel transit time (SBTT) were calculated for each group. Results: There was no significant difference in the number of VCEs that reached the cecum (32% failed to reach the cecum in the erythromycin group compared with 22% in the control group), GET, or SBTT between the two groups. Image quality was not adversely affected by the use of erythromycin. The dose and the preparation of erythromycin used in this study may have possibly had an effect on GET and SBTT. Conclusions: The use of erythromycin did not significantly increase the likelihood of the capsule reaching the cecum or affect the degree of visible peristalsis or the interpretation of capsule findings.